Chemotherapy treatment in BC promotes the degradation of SLC1A5 via RNF5 ubiquitination, leading to mTOR inactivation15, although we did not observe any association between the gene expression of SLC1A5 and RNF5 or its pseudogene RNFP1. This evidence concerns the gene MTOR and breast cancer.